ID   SMU-MFS
AC   CVCL_E6MG
SY   Sapporo Medical University hospital-MyxoFibroSarcoma
RX   PubMed=39625530;
CC   Population: Japanese.
CC   Characteristics: Tumorigenic (PubMed=39625530).
CC   Doubling time: ~24 hours (PubMed=39625530).
CC   Derived from site: In situ; Left forearm, hypodermis; UBERON=UBERON_0002386+UBERON_0002072.
ST   Source(s): PubMed=39625530
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 29,33.2
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 10,12
ST   Penta E: 9
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=39625530; DOI=10.1007/s13577-024-01157-9;
RA   Nakahashi, Naoya
RA   Emori, Makoto
RA   Takada, Kohichi
RA   Murahashi, Yasutaka
RA   Shimizu, Junya
RA   Murase, Kazuyuki
RA   Tsukahara, Tomohide
RA   Sugita, Shintaro
RA   Takasawa, Akira
RA   Iba, Kousuke
RA   Teramoto, Atsushi
RA   Osanai, Makoto
RT   "Establishment and characterization of the novel myxofibrosarcoma cell
RT   line, SMU-MFS.";
RL   Hum. Cell 38:25.1-25.10(2025).
//